Skip to main navigation Skip to search Skip to main content

Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician–patient partnership for early care of chronic beta cell failure. Reply to Mallone R, Bandini A [letter]

  • Stephen E. Gitelman
  • , Kimber Simmons
  • , Jennifer L. Sherr
  • , Teresa Quattrin
  • , William E. Russell
  • , Bhuvana Sunil
  • , Steven M. Willi
  • , Laura A. Knecht
  • , Elisabeth Niemoeller
  • , Idlir Licaj
  • , Diana Miller
  • , Linda A. DiMeglio
  • University of California at San Francisco
  • University of Colorado Anschutz Medical Campus
  • Yale University
  • Vanderbilt University
  • Mary Bridge Children’s Hospital
  • Children's Hospital of Philadelphia
  • University of Pennsylvania
  • Sanofi SA
  • Sanofi-Aventis
  • Cytel
  • Indiana University Bloomington

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1105-1106
Number of pages2
JournalDiabetologia
Volume69
Issue number4
DOIs
StatePublished - Apr 2026

Keywords

  • Diabetic ketoacidosis
  • Disease-modifying therapy
  • Presymptomatic
  • Screening
  • Type 1 diabetes

Fingerprint

Dive into the research topics of 'Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician–patient partnership for early care of chronic beta cell failure. Reply to Mallone R, Bandini A [letter]'. Together they form a unique fingerprint.

Cite this